feedback

Course Directors

Michael E. Thase, MD
Michael E. Thase, MD

Perelman School of Medicine
University of Pennsylvania
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania

Larry Culpepper, MD, MPH
Larry Culpepper, MD, MPH

Boston University School of Medicine
Boston, Massachusetts

Accredited by

Purdue University College of Pharmacy

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2016-Feb-29
Expiration Date:2018-Feb-27
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of Charge

Activity Description & Educational Objectives

In this activity, an expert in major depressive disorder discusses current guidelines and strategies for the diagnosis and ongoing assessment of patients suffering with this condition. The clinical utility of a variety of therapies is reviewed, along with practical approaches to achieving remission in these patients.

Upon completion of this activity, participants should be better able to:

  • Apply evidence-based treatments and current guidelines when managing individuals with major depressive disorder
  • Assess the clinical utility of new therapies in the management of patients with major depressive disorder
  • Use recommended approaches designed to achieve remission in patients with major depressive disorder who are either nonresponsive or suboptimally respond to their current treatment regimen
  • Employ validated symptom severity scales when making treatment decisions in patients with major depressive disorder

Target Audience

This activity has been designed to meet the educational needs of psychiatrists, internal medicine and family practice physicians, and other clinicians involved in treating patients with major depressive disorder.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: February 29, 2016 - February 28, 2018
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

All faculty AND staff involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Course Directors

Michael E. Thase, MD
Professor of Psychiatry
Director of Mood and Anxiety Disorders Section
Department of Psychiatry
Perelman School of Medicine
University of Pennsylvania
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania

Michael E. Thase, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Alkermes; Allergan; AstraZeneca; Bristol-Myers Squibb; Cerecor Inc.; Eli Lilly and Company; Fabre-Kramer Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Gerson Lehrman Group, Inc.; GlaxoSmithKline; Guidepoint Global, LLC; Lundbeck; MedAvante, Inc.; Merck & Co., Inc. (formerly Schering Plough and Organon); Moksha8 Pharmaceuticals Inc.; Naurex, Inc.; Neuronetics; Novartis Pharmaceuticals Corporation; Ortho-McNeil Pharmaceuticals (Johnson & Johnson; Janssen); Otsuka Pharmaceutical Co., Ltd.; Pamlab; Pfizer Inc. (formerly Wyeth Ayerst Pharmaceuticals); Pfizer Inc.; Shire; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Trius Therapeutics, Inc.
Grant/Research Support from Agency for Healthcare Research and Quality; Alkermes; AssureRx Health, Inc.; Avanir Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Janssen Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; and The National Institute of Mental Health.
Other Financial or Material Support from Royalties: American Psychiatric Foundation; Guilford Publications; Herald House; and W. W. Norton & Company, Inc.

Larry Culpepper, MD, MPH
Professor of Family Medicine
Boston University School of Medicine
Boston, Massachusetts

Larry Culpepper, MD, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant for Elsevier Press; Forest Laboratories, Inc.; Lundbeck; Merck & Co., Inc.; Shire PLC, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Shareholder in M-3 Information, LLC.
Advisory Board for Forest Laboratories, Inc.; Lundbeck; Merck & Co., Inc.; Shire PLC, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Other Financial or Material Support from Royalties: UpToDate, Inc. and Oxford University Press. Editor/Writer for Physicians Postgraduate Press where Dr. Culpepper serves as Editor in Chief of the Primary Care Companion for CNS Diseases.

Medical Director

Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education

Kirk A. Tacka, PhD, has no financial interests/relationships or affiliations in relation to this activity.

All additional planning committee members and reviewers, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University College of Pharmacy staff have no relationships to disclose.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

The Purdue University College of Pharmacy designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved by the American Board of Family Medicine for Family Medicine Certification Performance Improvement credit. Term of approval is for two years beginning September 21, 2016, with the option for yearly renewal thereafter.

The American Board of Psychiatry and Neurology has reviewed the 'Improving Remission Rates in Patients With Major Depressive Disorder in an Era of Updated Diagnostic Criteria and Expanding Treatment Options' and has approved this program as part of a comprehensive Performance in Practice (clinical module) program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME-MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

This CME activity is jointly provided by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education.

This activity is supported by educational grants from Allergan, Inc. and Otsuka America Pharmaceutical, Inc. and Lundbeck.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.